5th Annual CEE & CIS Clinical Trials Forum
Science Forum - Vienna, Austria
The increasing demand for eligible study patient populations in order to prepare markets for new medicines as well as the need for more cost-efficient clinical development programs are the key reasons why the pharma industry is conducting clinical trials in the CEE and CIS region. However, there are a number of challenges that all industry stakeholders need to overcome in order to conduct clinically and commercially successful trials.
Overview of the Challenges and Opportunities in the CEE & CIS
Optimizing Start-up Procedures
Conducting Clinical Trials in CEE & CIS
Revealing the Gaps in Compliance of Regulations with Global StandardsCurrent Situation in Running Clinical Trials in Countries throughout the CEE & CIS
Ukraine – Assessment of the Progress in the Recent Years
Romania, Bulgaria and CIS Countries and Clinical Trials
CEE Countries – Exploring the Clinical Trial Environment
Evaluation of Clinical Trials from Lithuanian Patient Perspective
Overview of Conducting Clinical Trials in Russian Federation
Bulgaria: Phase IV and Non-interventional Clinical Studies
(Photo courtesy of http://pharma.flemingeurope.com)
Wednesday, April 18, 2012 - Thursday, April 19, 2012
Hilton Vienna, Am Stadtpark 1, A-1030 Vienna, Austria
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
